OpenVSafe by OpenVAERS
Search V-safe

4XU-11857-84440

1 vaccination 3 coded responses 9 check-ins 3 free-text entries 1 call case
Sex
Female
Age at first dose
46-50
ZIP prefix
280 / NC
Registered
2020-12-30
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-30
    Registered in v-safe
  2. 2020-12-30
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Swelling · None
    Adult check-in
  4. 2021-01-01
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site pain, Self-medication — Feeling: Good · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness
    Free text: 1000mg tylenol night before injection, 1000mg morning of, must take 1000mg atvkeast every 10 hours to keep symptoms away. 3rd day post injection 500mg tylenol and no symptoms other than injection site tenderness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-01-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  7. 2021-01-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache, Fatigue or tiredness, Nausea
    Adult check-in
  8. 2021-01-06
    Health check-in — day 7, dose 1
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  9. 2021-01-13
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-03-31
    Survey response — 3 months, dose 1
    MedDRA: Alopecia, Arthritis, Dyspnoea, Fatigue, Joint swelling, Musculoskeletal stiffness, Pain, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activities
    Free text: Arthritis nodules occurred on fingers, joint swelling, pain and stiffness ( no previous hx.) Increased hair loss, fatigue and some noticable shortness of breath
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-12-30
    Survey response — 12 months, dose 1
    MedDRA: Ageusia, Anosmia, Cough, Dyspnoea, Fatigue, Headache, Medical counselling, SARS-CoV-2 test positive, Sinusitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: Headache, sinus infection, cough, loss taste & smell, extreme fatigue shortness of breath · Healthcare visit (other): Covid positive pharmacy PCR test
    MedDRA releases: 2024-11 · check-in free text available
  12. 2021-12-30
    Report sent to call center — 12 months, dose 1
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  13. 2022-01-05
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Vaccinations

DoseDateManufacturerCo-administered
12020-12-30Pfizer-BioNTech

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 1

2021-01-01

Systemic reaction (other): 1000mg tylenol night before injection, 1000mg morning of, must take 1000mg atvkeast every 10 hours to keep symptoms away. 3rd day post injection 500mg tylenol and no symptoms other than injection site tenderness

Release 6 — 3 months, dose 1

2021-03-31

Symptoms: Arthritis nodules occurred on fingers, joint swelling, pain and stiffness ( no previous hx.) Increased hair loss, fatigue and some noticable shortness of breath

Release 10 — 12 months, dose 1

2021-12-30

Symptoms: Headache, sinus infection, cough, loss taste & smell, extreme fatigue shortness of breath
Healthcare visit (other): Covid positive pharmacy PCR test

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOMedical counselling · · ✓
HCVOSARS-CoV-2 test positive · · ✓
SDAgeusia · · ✓
SDAlopecia ✓ ✓ ✓
SDAnosmia · · ✓
SDArthritis ✓ ✓ ✓
SDCough · · ✓
SDDyspnoea ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDHeadache · · ✓
SDJoint swelling ✓ ✓ ✓
SDMusculoskeletal stiffness ✓ ✓ ✓
SDPain ✓ ✓ ✓
SDPre-existing disease ✓ ✓ ✓
SDSinusitis · · ✓
SROInjection site pain ✓ ✓ ✓
SROSelf-medication ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release